Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. - Wikidata - awgldk - TriplyDB

Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

http://www.wikidata.org/entity/Q34091425

about

Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer Organoid Models of Human Gastrointestinal Development and Disease Hereditary diffuse gastric cancer: What the clinician should know Gastric Cancer in the Era of Precision Medicine.Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases.Organoid modeling for cancer precision medicine.Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.Recognition of and recent issues in hereditary diffuse gastric cancer.Kidney Organoids: A Translational Journey.Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.Impacts of Early Life Stress on the Methylome and Transcriptome of Atlantic Salmon.Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.Cancer genomics just got personal.One patient, two lesions, two oncogenic drivers of gastric cancer.Oncogenic Transformation of Human-Derived Gastric Organoids.Humans in a Dish: The Potential of Organoids in Modeling Immunity and Infectious Diseases.MiR-155 promotes gastric cancer growth and invasion by negatively regulating Transforming Growth Factor Beta Receptor 2.Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors.Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma.Organoids Provide an Important Window on Inflammation in Cancer.Proposed Molecular and miRNA Classification of Gastric Cancer.Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway

P2860

Q26764932-35CA78E3-4268-4114-A0DE-618F67FA2A8B Q26771646-0579FCB2-64FC-4729-8C9A-0449236D5C35 Q26784215-18028390-AE83-4E7B-B8D3-9467FD82F742 Q33600457-68DA9C7D-DA8A-4AC0-8524-99C8522A106F Q33815218-5DB698DD-27EB-425B-A635-34BF8B2D11D1 Q34669048-C3632ACB-FC06-42BD-9F3F-59EEDEE3F901 Q35331865-0561CB11-8DD9-4D5C-A511-B28E3B799A45 Q36859396-9CD4F339-F039-44B0-B803-E02333516D15 Q38518256-47FEA3BB-EC26-4155-BD85-2BF94158B3B6 Q38558317-356AAE14-EE3B-42D6-8F3D-D1804394B217 Q38651789-8C6510AD-F801-4FA9-A6BE-3BB8AC3DDD8D Q39257719-466CFF23-E6A1-4CCD-9B1C-968107C3251E Q39399293-C030A75D-5F8C-44BF-9C91-BF840D627CFD Q42027887-F91FE416-C936-4D3D-847A-EBCDA21116C2 Q42153979-A34949D8-7C0C-4E40-9889-4BC53BB1A1A0 Q43730011-9D3BC0D1-0115-447A-8E7E-7A0330C4BD37 Q47094121-DD1D1A82-2485-462C-B928-98B7D97DE1B5 Q47286792-5A2DED0D-D1CC-4B47-AC18-F188CDD1D344 Q47654322-FD792450-0349-4F76-9B15-83786C71E483 Q47722500-B3B6CD7C-C783-4B50-A51B-6F5774451632 Q47761940-608EF115-E294-4444-8E67-D969DCE01B26 Q48308780-781FFBE7-EDA2-4681-9FE2-42029BC00FB3 Q48690318-25795DC8-3CC1-4E4C-BAED-C901F4A8B91F Q49184931-26145C50-05D9-4359-9098-051F155E776D Q50130134-4CDCE924-EFF1-444B-9B0E-5777AC2EBEA9 Q50470371-C5430A3B-676C-4412-9CF3-890EC8250288 Q55302559-02180AEF-42C4-48C5-A35E-57294E8CE2E6 Q55603677-653CF81D-FD03-4934-8D89-212B73B5CB11 Q57116103-5388C959-49A9-4DD8-ACC2-F2E11D5DE167

P2860

Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

http://www.wikidata.org/entity/Q34091425

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@ast

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@en

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@nl

type

label

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@ast

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@en

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@nl

prefLabel

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@ast

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@en

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@nl

P1433

Q34091425-894A728B-A0DD-4E15-9167-0A6C63F41A80

P1476

Q34091425-BE69368E-B1C9-4E0A-90E3-2B36622AA83A

P2093

Q34091425-0F2DE3B1-35C0-45F1-A86C-6CEA0DADC149

Q34091425-1031D3C2-E152-42AC-83D6-D18E835E29A1

Q34091425-1601297D-F321-45B6-A328-ACC13163D9DC

Q34091425-357BE85E-E38E-41EB-9C5D-61D2F1A21D9A

Q34091425-46D68B74-06FF-442F-8BB3-D92CFDE01987

Q34091425-61049E80-B28A-433B-B3F0-9A954B2D9C2C

Q34091425-7BBE7065-C1F6-4EAE-A515-A7A2382DAAD9

Q34091425-7BFD62FB-A865-4772-9EFC-14F858E49F81

Q34091425-8AD37BAB-8B65-4C76-A0CC-8A282D9EE1EA

Q34091425-A1D31429-DDC4-4EF7-A12F-792235DBC7C2

P2860

Q34091425-092214A9-6EB9-434F-B170-90FAAEDB29D8

Q34091425-0AF65F4C-EA24-4541-8B9D-D0CE717C0BE2

Q34091425-0FC49A1B-96F0-44F4-BFB4-92465AF248C5

Q34091425-170AAA1A-D219-4B6A-9B61-0135821CFC15

Q34091425-17B45E85-7E86-4CC1-ABAE-A5133EA76307

Q34091425-1F13A606-50A9-4095-95F5-22F903EE8A37

Q34091425-202822C0-228C-4C81-80D6-76628CD6FAF9

Q34091425-23E8A6E5-467C-4D00-A5E4-B2400C867639

Q34091425-32044CC9-D25B-48C8-91F3-166DCA9E30B0

Q34091425-34E9DC16-7E82-4FED-BAC2-79936FC583EA

P2888

Q34091425-C9ABD0C4-D89C-469F-971D-D9B232EEDD86

P304

Q34091425-FBBF4CE5-1CCA-422F-9360-6ECFCFE86DA3

P31

Q34091425-5016C6FE-297A-4F63-84C5-92C56F611016

P356

Q34091425-CD64D6B9-9D5D-4A62-94B3-19E9F077AA61

P433

Q34091425-9FED8767-B369-4CBA-BDAC-F074307E2734

P478

Q34091425-E2FA430B-DB9D-4A84-B628-E1CC0183B4AE

P50

Q34091425-7828B9A4-14AB-44E9-ABA1-7F288ACB474F

P577

Q34091425-6E2576C8-841A-4331-B0ED-611EA75CD2BD

P5875

Q34091425-7D2D919E-F947-4351-9B10-EA8F4A1C51F3

P6179

Q34091425-7C22E572-6716-4566-B4CF-F6FA98BD3786

P698

Q34091425-97FEB047-51F3-44B6-822C-6B7EFAAB0EB0

P932

Q34091425-CB5BEC01-A2A6-40DD-87F5-49545D53AE9E

P356

S13059-014-0428-9

P1433

P1476

Metastatic tumor evolution and ...... ver in diffuse gastric cancer.

@en

P2093

Akifumi Ootani

http://www.w3.org/2001/XMLSchema#string

Calvin J Kuo

http://www.w3.org/2001/XMLSchema#string

Curt Palm

http://www.w3.org/2001/XMLSchema#string

Erik S Hopmans

http://www.w3.org/2001/XMLSchema#string

Georges Natsoulis

http://www.w3.org/2001/XMLSchema#string

Hanlee P Ji

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Hua Xu

http://www.w3.org/2001/XMLSchema#string

John F Regan

http://www.w3.org/2001/XMLSchema#string

John M Bell

http://www.w3.org/2001/XMLSchema#string

P2860

Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads

E-cadherin gene mutations provide clues to diffuse type gastric carcinomas

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

dbSNP: the NCBI database of genetic variation

A map of human genome variation from population-scale sequencing

Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint library

Velvet: algorithms for de novo short read assembly using de Bruijn graphs

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

A method and server for predicting damaging missense mutations

P2888

s13059-014-0428-9

P304

428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13059-014-0428-9

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266946659

http://www.w3.org/2001/XMLSchema#string

P6179

1003272821

http://www.w3.org/2001/XMLSchema#string

P698

25315765

http://www.w3.org/2001/XMLSchema#string

P932

4145231

http://www.w3.org/2001/XMLSchema#string